How Has The Smc Patient And Clinician Engagement (Pace) Process Been Used In Assessments Of End-Of-Life Medicines And Medicines To Treat Very Rare Conditions?
Abstract
Authors
C Akesson C Jones J McKendrick C Grant
C Akesson C Jones J McKendrick C Grant
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now